Lifecore Biomedical Inc

Lifecore Biomedical Inc

LFCR

Get informed when a big investor buys or sells

+ Follow
Market Cap$165.79M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Lifecore Biomedical IncLifecore Biomedical Inc-4.8--164%1.57.5
$6.25

Target Price by Analysts

42.4% upsideLifecore Biomedical Target Price DetailsTarget Price
$8.82

Current Fair Value

101% upside

Undervalued by 101% based on the discounted cash flow analysis.

Share Statistics

Market cap$165.79 Million
Enterprise Value$301.00 Million
Dividend Yield$- (-)
Earnings per Share$-0.92
Beta1.06
Outstanding Shares37,477,386

Return

Return on Equity-164.06%ROE
Return on Assets-15.12%
Return on Invested Capital-1.61%

Valuation & Multiples

P/E Ratio-4.8P/E Ratio
PEG-336.28PEG
Price to Sales1.46Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue2.38
Enterprise Value to EBIT-90.99
Enterprise Value to Net Income-9
Total Debt to Enterprise0.52
Debt to Equity7.51Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 31, 2026
EPS Estimate
$-0.24
Average shareholder expectation
Revenue Estimate
$30.08 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 5, 2026
EPS Estimate
$-0.22
Average shareholder expectation
Revenue Estimate
$32.02 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 77.99%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.61% 66.40%
Total Invested$1.09M 99.03%
Investors Holding17 91.00%

ESG Score

No data

About Lifecore Biomedical Inc

796 employees
CEO: Albert Bolles

Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the foo...